Literature DB >> 17646286

Choosing where to look next in a mutation sequence space: Active Learning of informative p53 cancer rescue mutants.

Samuel A Danziger1, Jue Zeng, Ying Wang, Rainer K Brachmann, Richard H Lathrop.   

Abstract

MOTIVATION: Many biomedical projects would benefit from reducing the time and expense of in vitro experimentation by using computer models for in silico predictions. These models may help determine which expensive biological data are most useful to acquire next. Active Learning techniques for choosing the most informative data enable biologists and computer scientists to optimize experimental data choices for rapid discovery of biological function. To explore design choices that affect this desirable behavior, five novel and five existing Active Learning techniques, together with three control methods, were tested on 57 previously unknown p53 cancer rescue mutants for their ability to build classifiers that predict protein function. The best of these techniques, Maximum Curiosity, improved the baseline accuracy of 56-77%. This article shows that Active Learning is a useful tool for biomedical research, and provides a case study of interest to others facing similar discovery challenges.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17646286      PMCID: PMC2811495          DOI: 10.1093/bioinformatics/btm166

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  33 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

2.  Surfing the p53 network.

Authors:  B Vogelstein; D Lane; A J Levine
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

Review 3.  Transcriptional repression mediated by the p53 tumour suppressor.

Authors:  J Ho; S Benchimol
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

4.  Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites.

Authors:  Hua Qian; Ting Wang; Louie Naumovski; Charles D Lopez; Rainer K Brachmann
Journal:  Oncogene       Date:  2002-11-07       Impact factor: 9.867

5.  Genetic strategies in Saccharomyces cerevisiae to study human tumor suppressor genes.

Authors:  Takahiko Kobayashi; Ting Wang; Hua Qian; Rainer K Brachmann
Journal:  Methods Mol Biol       Date:  2003

6.  Functional census of mutation sequence spaces: the example of p53 cancer rescue mutants.

Authors:  Samuel A Danziger; S Joshua Swamidass; Jue Zeng; Lawrence R Dearth; Qiang Lu; Jonathan H Chen; Jianlin Cheng; Vinh P Hoang; Hiroto Saigo; Ray Luo; Pierre Baldi; Rainer K Brachmann; Richard H Lathrop
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2006 Apr-Jun       Impact factor: 3.710

Review 7.  Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome.

Authors:  A Sigal; V Rotter
Journal:  Cancer Res       Date:  2000-12-15       Impact factor: 12.701

Review 8.  Rescuing the function of mutant p53.

Authors:  A N Bullock; A R Fersht
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

Review 9.  Assessing TP53 status in human tumours to evaluate clinical outcome.

Authors:  T Soussi; C Béroud
Journal:  Nat Rev Cancer       Date:  2001-12       Impact factor: 60.716

10.  The IARC TP53 database: new online mutation analysis and recommendations to users.

Authors:  Magali Olivier; Ros Eeles; Monica Hollstein; Mohammed A Khan; Curtis C Harris; Pierre Hainaut
Journal:  Hum Mutat       Date:  2002-06       Impact factor: 4.878

View more
  10 in total

1.  An economic framework to prioritize confirmatory tests after a high-throughput screen.

Authors:  S Joshua Swamidass; Joshua A Bittker; Nicole E Bodycombe; Sean P Ryder; Paul A Clemons
Journal:  J Biomol Screen       Date:  2010-06-14

2.  An active role for machine learning in drug development.

Authors:  Robert F Murphy
Journal:  Nat Chem Biol       Date:  2011-06       Impact factor: 15.040

3.  Structures of oncogenic, suppressor and rescued p53 core-domain variants: mechanisms of mutant p53 rescue.

Authors:  Brad D Wallentine; Ying Wang; Vira Tretyachenko-Ladokhina; Martha Tan; Donald F Senear; Hartmut Luecke
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-09-20

4.  Predicting transcriptional activity of multiple site p53 mutants based on hybrid properties.

Authors:  Tao Huang; Shen Niu; Zhongping Xu; Yun Huang; Xiangyin Kong; Yu-Dong Cai; Kuo-Chen Chou
Journal:  PLoS One       Date:  2011-08-08       Impact factor: 3.240

5.  An indicator cell assay for blood-based diagnostics.

Authors:  Samuel A Danziger; Leslie R Miller; Karanbir Singh; G Adam Whitney; Elaine R Peskind; Ge Li; Robert J Lipshutz; John D Aitchison; Jennifer J Smith
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

Review 6.  Roles of computational modelling in understanding p53 structure, biology, and its therapeutic targeting.

Authors:  Yaw Sing Tan; Yasmina Mhoumadi; Chandra S Verma
Journal:  J Mol Cell Biol       Date:  2019-04-01       Impact factor: 6.216

7.  Predicting positive p53 cancer rescue regions using Most Informative Positive (MIP) active learning.

Authors:  Samuel A Danziger; Roberta Baronio; Lydia Ho; Linda Hall; Kirsty Salmon; G Wesley Hatfield; Peter Kaiser; Richard H Lathrop
Journal:  PLoS Comput Biol       Date:  2008-09-04       Impact factor: 4.475

8.  Prediction of P53 mutants (multiple sites) transcriptional activity based on structural (2D&3D) properties.

Authors:  R Geetha Ramani; Shomona Gracia Jacob
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

9.  Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53.

Authors:  Christopher D Wassman; Roberta Baronio; Özlem Demir; Brad D Wallentine; Chiung-Kuang Chen; Linda V Hall; Faezeh Salehi; Da-Wei Lin; Benjamin P Chung; G Wesley Hatfield; A Richard Chamberlin; Hartmut Luecke; Richard H Lathrop; Peter Kaiser; Rommie E Amaro
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

10.  Deciding when to stop: efficient experimentation to learn to predict drug-target interactions.

Authors:  Maja Temerinac-Ott; Armaghan W Naik; Robert F Murphy
Journal:  BMC Bioinformatics       Date:  2015-07-09       Impact factor: 3.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.